PeptiGrowth Inc. is Launching a Novel Synthetic FGF2 Alternative Peptide (FGFR1c Agonist)
PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo; President: Jiro Sugimoto) has successfully developed a novel synthetic ...
InStyle on MSN1 天
I Tried Fractional Laser Resurfacing—It Did What Skin Care Couldn’t for My Acne Scars
Few treatments can compete with lasers for targeting fine lines, wrinkles, and other skin texture concerns. Fractional lasers ...
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
Event: 2024 Cell & Gene Meeting on the Mesa Session Date and Time: October 7, 2024, at 5:45 p.m. MST Location: FLW Ballroom F For more information, please visit FibroBiologics' website or email ...
techexplorist2 天
A new hope for preventing heart failure and reducing fibrosis
As people age, more patients are developing heart failure. A study from Nagoya University found that an enzyme called PKN is ...
manilatimes2 天
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of ...
Zhejiang Doer Biologics Co., Ltd. ('Doer Bio'), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its ...
PsyPost on MSN5 天
Liver hormone FGF21 may play key role in alcohol use disorder, study suggests
A recent study published in the journal Alcohol suggests that a liver hormone, fibroblast growth factor 21 (FGF21), may play ...